Multifidus dysfunction and restorative neurostimulation: a scoping review.

Journal Information

Full Title: Pain Med

Abbreviation: Pain Med

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Psychophysiology

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Conflicts of interest: V.T.F. reports investigator-initiated study research grant from Nevro. V.T.F. holds unpaid leadership position with ASPN. B.D.W. has no conflicts of interest. A.G.C. has research fees paid to institution in his name from Aspen, DARPA, NIH, and Mainstay. A.G,C. holds leadership positions in ASPN, ASRA, RISIPP, AAPMR, AAOE, all unpaid. A.G.C. is the CEO of Pain Spine and Rehabilitation Consulting without conflicts of interest related to this manuscript. DS reports grants from Boston Scientific; personal fees from Medtronic, Nevro, Saluda, Painteq (with options), Vertos (with options), SPR (with options), Mainstay (with options), and Surgentec. DS has no conflicts of interest directly related to this manuscript."

Evidence found in paper:

"Funding The authors report no funding associated with this study. Conflicts of interest: V.T.F. reports investigator-initiated study research grant from Nevro. V.T.F. holds unpaid leadership position with ASPN. B.D.W. has no conflicts of interest. A.G.C. has research fees paid to institution in his name from Aspen, DARPA, NIH, and Mainstay. A.G,C. holds leadership positions in ASPN, ASRA, RISIPP, AAPMR, AAOE, all unpaid. A.G.C. is the CEO of Pain Spine and Rehabilitation Consulting without conflicts of interest related to this manuscript. DS reports grants from Boston Scientific; personal fees from Medtronic, Nevro, Saluda, Painteq (with options), Vertos (with options), SPR (with options), Mainstay (with options), and Surgentec. DS has no conflicts of interest directly related to this manuscript."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025